Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The vitamin D endocrine system is essential for calcium and phosphate homeostasis and skeletal mineralization. The 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) hormone binds to the vitamin D receptor (VDR) to regulate gene expression. These gene products in turn mediate the actions of 1,25(OH)(2)D(3) in mineral-regulating target cells such as the osteoblast. We showed previously that
meningioma 1
(
MN1
) is a novel target of 1,25(OH)(2)D(3) in MG-63 osteoblastic cells and that it is a coactivator for VDR-mediated transcription (Sutton, A. L., Zhang, X., Ellison, T. I., and MacDonald, P. N. (2005) Mol. Endocrinol. 19, 2234-2244). However, the functional significance of
MN1
in osteoblastic cell biology is largely unknown. Here, we demonstrate that
MN1
expression is increased dramatically during differentiation of primary osteoblastic cells. Using calvarial osteoblasts derived from wild-type and
MN1
knock-out mice, we provide data supporting an essential role of
MN1
in maintaining appropriate osteoblast proliferation, differentiation, and function.
MN1
knock-out osteoblasts displayed altered morphology, decreased growth rate, impaired motility, and attenuated 1,25(OH)(2)D(3)/VDR-mediated transcription as well as reduced
alkaline phosphatase
activity and mineralized nodule formation.
MN1
null osteoblasts were also impaired in supporting osteoclastogenesis in co-culture studies presumably because of marked reduction in the RANKL:OPG ratio in the
MN1
null cells. Mechanistic studies supported a transcriptional role for
MN1
in controlling RANKL gene expression through activation of the RANKL promoter. Cumulatively, these studies indicate an important role for
MN1
in maintaining the appropriate maturation and function of calvarial osteoblasts.
...
PMID:Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function. 1938 90